A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

Clinical trial NCT05421078 · COMPLETED

Trial details

NCT number: NCT05421078
Sponsor: NewAmsterdam Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemia Hypercholesterolemia High Cholesterol

Start date: 2022-06-27
Primary completion: 2023-03-24
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.